Dysregulated expression of the Parkinson’s disease gene PARK2 was previously found in the spinal cord and motor cortex samples of sALS patients, as well as in ALS animal models, supporting this gene as a disease modifier in ALS pathogenesis [75,76,77]. This evidence concerns the gene PRKN and Parkinson disease.